Inquiry Basket
Catalog | Product Name | CAS Number |
---|---|---|
BADC-01688 | Dap-Phe | 161485-87-6 |
Dap-Phe is a dipeptide that features Dap and Phe. Dap-Phe can be used in peptide synthesis and biochemical research. Its unique structure, incorporating Dap, allows for the study of peptides with additional amino groups, which can affect the peptide's chemical and biological properties. Such modifications can be important for exploring new peptide-based drugs, studying protein interactions, or investigating enzyme-substrate specificity. It is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
BADC-01690 | Dap-D-Phe hydrochloride | |
Dap-D-Phe hydrochloride is the isomer of Dap-Phe hydrochloride, which is a dipeptide that features Dap and Phe. Dap-Phe can be used in peptide synthesis and biochemical research. Its unique structure, incorporating Dap, allows for the study of peptides with additional amino groups, which can affect the peptide's chemical and biological properties. Such modifications can be important for exploring new peptide-based drugs, studying protein interactions, or investigating enzyme-substrate specificity. It is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
BADC-01702 | Dap-Phe hydrochloride | 864238-20-0 |
Dap-Phe hydrochloride is a dipeptide that features Dap and Phe. Dap-Phe can be used in peptide synthesis and biochemical research. Its unique structure, incorporating Dap, allows for the study of peptides with additional amino groups, which can affect the peptide's chemical and biological properties. Such modifications can be important for exploring new peptide-based drugs, studying protein interactions, or investigating enzyme-substrate specificity. It is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
BADC-01713 | D-Val-L-Cit-PAB | 2088364-35-4 |
D-Val-L-Cit-PAB is a synthetic linker compound used in drug development and delivery systems, particularly in ADCs. The linker includes D-valine and L-citrulline, providing specific sites for enzymatic cleavage, and the para-aminobenzyloxycarbonyl group, which facilitates the release of the drug payload once the linker is cleaved within the target cell. This design allows for targeted and controlled drug release, enhancing the efficacy and reducing the toxicity of the therapeutic agents. | Inquiry | |
BADC-01747 | D-Val-D-Cit-PAB | |
D-Val-D-Cit-PAB is a synthetic linker compound used in drug development and delivery systems, particularly in ADCs. The linker includes D-valine and D-citrulline, providing specific sites for enzymatic cleavage, and the para-aminobenzyloxycarbonyl group, which facilitates the release of the drug payload once the linker is cleaved within the target cell. This design allows for targeted and controlled drug release, enhancing the efficacy and reducing the toxicity of the therapeutic agents. | Inquiry | |
BADC-01999 | L-Val-D-Cit-PAB | 2226490-91-9 |
L-Val-D-Cit-PAB is a synthetic linker compound used in drug development and delivery systems, particularly in ADCs. The linker includes L-valine and D-citrulline, providing specific sites for enzymatic cleavage, and the para-aminobenzyloxycarbonyl group, which facilitates the release of the drug payload once the linker is cleaved within the target cell. This design allows for targeted and controlled drug release, enhancing the efficacy and reducing the toxicity of the therapeutic agents. | Inquiry | |
BADC-01591 | Boc-Dap-OH | 120205-50-7 |
Boc-Dap-OH is a pivotal compound extensively utilized in the biomedical sector. It assumes a fundamental function in the amalgamation of diverse pharmaceutical remedies and peptides. This indispensable product profoundly contributes to the progression of therapeutics targeting ailments like cancer and viral infections. | Inquiry | |
BADC-01586 | Fmoc-Gly-Gly-Gly-Gly-OH | 1001202-16-9 |
Fmoc-Gly-Gly-Gly-Gly-OH is an inherent constituent within the biomedical realm. It serves as a pivotal foundational constituent in the conduction of peptide and peptidomimetic synthesis. With its pervasive utilization in the domain of pharmaceutical research and investigation, particularly in the fields of oncology, immunology, and neuroscience, it evinces auspicious prospects for therapeutic application. | Inquiry |